United States - English - NLM (National Library of Medicine)

innovida pharmaceutique corporation - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) - lidocaine 70 mg in 1 g - lidocaine and tetracaine cream is indicated for use on intact skin in adults to provide topical local analgesia for superficial dermatological procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal. - lidocaine and tetracaine cream is contraindicated in patients with a known history of sensitivity to lidocaine or tetracaine, local anesthetics of the amide or ester type, or to any other component of the product [ see warnings and precautions (5.4) ]. - lidocaine and tetracaine cream is contraindicated in patients with para-aminobenzoic acid (paba) hypersensitivity. risk summary there are no available data on lidocaine and tetracaine cream use in pregnant women to determine a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. available data from an epidemiologic study and case series with parenteral lidocaine use in pregnant women have not identified a drug-a

United States - English - NLM (National Library of Medicine)

softap inc - tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv), lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987) - - lidocaine usp - 3% topical anesthetic - tetracaine usp - 2% topical anesthetic - on adults over 18 only - temporarily relieves pain due to cuts, scrapes, or abrasions - with occlusion - if you have a known allergy or sensitivity to any ingredients - if pregnant or breastfeeding - on large areas of the body - in large quantities. apply only 1-2ml to desired area - if you have a history of liver disease or impairment - if safety seal is broken before first use

United States - English - NLM (National Library of Medicine)

sae, llc - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) - lidocaine and tetracaine cream is indicated for use on intact skin in adults to provide topical local analgesia for superficial dermatological procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal. - lidocaine and tetracaine cream is contraindicated in patients with a known history of sensitivity to lidocaine or tetracaine, local anesthetics of the amide or ester type, or to any other component of the product [see warnings and precautions (5.4) ]. - lidocaine and tetracaine cream is contraindicated in patients with para-aminobenzoic acid (paba) hypersensitivity. risk summary there are no available data on lidocaine and tetracaine cream use in pregnant women to determine a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. available data from an epidemiologic study and case series with parenteral lidocaine use in pregnant women have not identified a drug-associated risk of major birth defec

United States - English - NLM (National Library of Medicine)

galderma laboratories, l.p. - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) - lidocaine 70 mg in 1 g - pliaglis cream is a combination of lidocaine, an amide local anesthetic, and tetracaine, an ester local anesthetic, and is indicated for use on intact skin in adults to provide topical local analgesia for superficial dermatological procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal. - pliaglis cream is contraindicated in patients with a known history of sensitivity to lidocaine or tetracaine, local anesthetics of the amide or ester type, or to any other component of the product [see warnings and precautions (5.4)]. - pliaglis cream is contraindicated in patients with para-aminobenzoic acid (paba) hypersensitivity. pregnancy category b. no adequate and well-controlled studies have been conducted in pregnant women. pliaglis cream should be used during pregnancy only if the potential benefit justifies risk to the fetus. lidocaine was not teratogenic in rats at doses up to 60 mg/kg (8-fold higher than the level of lidocaine contained

United States - English - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) - lidocaine 70 mg in 1 g - pliaglis is indicated for use on intact skin in adults to provide topical local analgesia for superficial dermatological procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal. - pliaglis is contraindicated in patients with a known history of sensitivity to lidocaine or tetracaine, local anesthetics of the amide or ester type, or to any other component of the product [see warnings and precautions (5.4) ]. - pliaglis is contraindicated in patients with para-aminobenzoic acid (paba) hypersensitivity. risk summary there are no available data on pliaglis use in pregnant women to determine a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. available data from an epidemiologic study and case series with parenteral lidocaine use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. published data on tetracain

United States - English - NLM (National Library of Medicine)

galen us incorporated - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) - lidocaine 70 mg - synera is a combination amide and ester local anesthetic indicated for use on intact skin to provide local dermal analgesia for superficial venous access and superficial dermatological procedures such as excision, electrodessication and shave biopsy of skin lesions [see clinical studies ( 14)] . - synera is contraindicated in patients with a known history of sensitivity to lidocaine, tetracaine, or local anesthetics of the amide or ester type. - synera is also contraindicated in patients with para-aminobenzoic acid (paba) hypersensitivity and in patients with a known history of sensitivity to any other component of the product. risk summary there are no available data on synera use in pregnant women to determine a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. available data from an epidemiologic study and case series with parenteral lidocaine use in pregnant women have not iden

United States - English - NLM (National Library of Medicine)

sincerus florida, llc - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) -

United States - English - NLM (National Library of Medicine)

m2b pharma llc - benzocaine (unii: u3rsy48jw5) (benzocaine - unii:u3rsy48jw5), tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv), lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987) - topical anesthetic topical analgesic topical analgesic for temporary relief of pain

United States - English - NLM (National Library of Medicine)

sincerus florida, llc - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) -

United States - English - NLM (National Library of Medicine)

sincerus florida, llc - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) -